Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kees

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Arzneimittel-Forschung|April 1, 1989
Pharmacokinetics of ciprofloxacin in elderly patientsF Kees, K G Naber, G P Meyer, et al.
Arzneimittel-Forschung|April 1, 1987
[The bioavailability of midodrin and alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride]H Grobecker, F Kees, M Linden, et al.
Arzneimittel-Forschung|September 1, 1990
[The bioavailability of doxycycline]F Kees, R Dehner, W Dittrich, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failureH Grobecker, I Gessler, W Delius, et al.
The American Journal of Medicine|November 30, 1989
Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administrationK G Naber, F Sörgel, F Kees, et al.
The European Respiratory Journal|July 1, 1994
The levels of clarithromycin and its 14-hydroxy metabolite in the lungD Honeybourne, F Kees, J M Andrews, et al.
Arzneimittel-Forschung|March 1, 1990
Relative bioavailability of three cefixime formulationsF Kees, K G Naber, G Sigl, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 16, 2007
Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of NeoimmunF Kees, M Bucher, F Schweda, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1986
Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infectionsK G Naber, G A Dette, F Kees, et al.
British Journal of Clinical Pharmacology|December 12, 2001
Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteersF Kees, L Färber, M Bucher, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Arzneimittel-Forschung|April 1, 1989
Pharmacokinetics of ciprofloxacin in elderly patientsF Kees, K G Naber, G P Meyer, et al.
Arzneimittel-Forschung|April 1, 1987
[The bioavailability of midodrin and alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride]H Grobecker, F Kees, M Linden, et al.
Arzneimittel-Forschung|September 1, 1990
[The bioavailability of doxycycline]F Kees, R Dehner, W Dittrich, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failureH Grobecker, I Gessler, W Delius, et al.
The American Journal of Medicine|November 30, 1989
Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administrationK G Naber, F Sörgel, F Kees, et al.
The European Respiratory Journal|July 1, 1994
The levels of clarithromycin and its 14-hydroxy metabolite in the lungD Honeybourne, F Kees, J M Andrews, et al.
Arzneimittel-Forschung|March 1, 1990
Relative bioavailability of three cefixime formulationsF Kees, K G Naber, G Sigl, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 16, 2007
Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of NeoimmunF Kees, M Bucher, F Schweda, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1986
Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infectionsK G Naber, G A Dette, F Kees, et al.
British Journal of Clinical Pharmacology|December 12, 2001
Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteersF Kees, L Färber, M Bucher, et al.
Pageof 8